About Nuvalent, Inc. 
Nuvalent, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 63 Schemes (39.54%)
Foreign Institutions
Held by 112 Foreign Institutions (9.82%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-100 Million
Pharmaceuticals & Biotechnology
USD 7,335 Million ()
NA (Loss Making)
NA
0.00%
-1.12
-41.73%
8.68






